MARSHALL WACE, LLP - GENOMIC HEALTH INC ownership

GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 220 filers reported holding GENOMIC HEALTH INC in Q3 2019. The put-call ratio across all filers is 3.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of GENOMIC HEALTH INC
ValueSharesWeighting
Q3 2019$506,000
-86.3%
7,468
-88.2%
0.00%
-86.7%
Q2 2019$3,693,000
+232.4%
63,484
+48.0%
0.03%
+233.3%
Q2 2016$1,111,000
+2.9%
42,896
-1.6%
0.01%
-10.0%
Q1 2016$1,080,000
-82.3%
43,599
-74.8%
0.01%
-82.5%
Q4 2015$6,097,000173,2190.06%
Other shareholders
GENOMIC HEALTH INC shareholders Q3 2019
NameSharesValueWeighting ↓
Camber Capital Management LP 2,150,000$68,736,0004.57%
Baker Brothers Advisors 13,656,318$436,592,0004.46%
NORTH TIDE CAPITAL, LLC 1,500,000$47,955,0003.22%
Motley Fool Wealth Management, LLC 72,732$2,325,0001.36%
Tributary Capital Management, LLC 150,896$4,824,0000.82%
Champlain Investment Partners, LLC 1,217,175$38,913,0000.62%
Motley Fool Asset Management LLC 71,935$2,300,0000.43%
IRONBRIDGE CAPITAL MANAGEMENT LP 440,410$14,080,0000.39%
CATAPULT CAPITAL MANAGEMENT LLC 35,000$1,119,0000.28%
Spark Investment Management LLC 51,100$1,633,0000.27%
View complete list of GENOMIC HEALTH INC shareholders